Journal profile · Medicine-Radiology, Nuclear Medicine and Imaging
Sarcoma
ISSN 1357-714X · eISSN 1369-1643 · Hindawi · United Kingdom
FollowGet an email when its zone, impact factor or warning status changes
Sarcoma: fully open access; APC about USD 820; median 183 days to acceptance (103 articles, last 24 months); 0 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Sarcoma is published by Hindawi. By OpenAlex counts of its recent articles, its largest topics are Sarcoma Diagnosis and Treatment, Bone Tumor Diagnosis and Treatments and Cardiac tumors and thrombi, together about 61.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Sarcoma is dedicated to publishing papers covering all aspects of connective tissue oncology research. It brings together work from scientists and clinicians carrying out a broad range of research in this field, including the basic sciences, molecular biology and pathology and the clinical sciences of epidemiology, surgery, radiotherapy and chemotherapy. High-quality papers concerning the entire range of bone and soft tissue sarcomas in both adults and children, including Kaposi’s sarcoma, are published as well as preclinical and animal studies. This journal provides a central forum for the description of advances in diagnosis, assessment and treatment of this rarely seen, but often mismanaged, group of patients. It is of interest to all those working with bone and soft tissue tumours, including medical, surgical and paediatric oncologists, radiotherapists, pathologists and research scientists.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Radiology, Nuclear Medicine and Imaging
Editorial board by country: none in mainland China; most named United States 8, India 2, Italy 2, Taiwan, China 1, United Kingdom 1 (20 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sarcoma Diagnosis and TreatmentMedicine40.6%
- Bone Tumor Diagnosis and TreatmentsMedicine12.8%
- Cardiac tumors and thrombiMedicine8.5%
- Vascular Tumors and AngiosarcomasMedicine4.6%
- Chromatin Remodeling and CancerBiochemistry, Genetics and Molecular Biology3.8%
- Soft tissue tumor case studiesMedicine3.6%
- Acute Lymphoblastic Leukemia researchMedicine2.4%
- Neurofibromatosis and Schwannoma CasesMedicine2.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | Q2 | 114/361 | 68th |
| Oncology | Q2 | 198/428 | 53rd |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedEmbaseCASCINAHLDOAJPublisher website
Other: Google Scholar, EBSCO, ProQuest, CNKI, J-Gate
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
- CiteScore 2026-06
- 4.3LetPub ·
- SJR 2026-06
- 0.56LetPub ·
- SNIP 2026-06
- 1.45LetPub ·
- h-index
- 65OpenAlex ·
- i10-index
- 520OpenAlex ·
- 2-year mean citedness
- 4.89OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 815 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 861 |
| 2025 | 0 | 0 | 1,273 |
| 2024 | 9 | 8 | 1,461 |
| 2023 | 4 | 4 | 1,574 |
| 2022 | 18 | 17 | 1,701 |
| 2021 | 25 | 25 | 1,865 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
183 daysMedian, submission to acceptance · P25–P75 131 days – 257 days
- Acceptance to online
- median 34 days (103 articles)
- Submission to online
- median 218 days
- Sample
- 103 articles with submission and acceptance dates (182 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 14 weeksLetPub ·
- Peer review
- Anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 820 | — | — | |
| LetPub | USD 800 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 300 words
- Reference style
- Chicago
- First submission
- Free format: the journal's layout is not required
Article types accepted5
- original researchThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- research articleThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- reviewThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- review articleThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- systematic reviewThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Peer review, Preprints, Trial registration / reporting guidelines
- Authorship Title and authorship information
The following information should be included: Manuscript title Full author names Full institutional mailing addresses Email addresses Affiliations. The publisher remains neutral with regard to jurisdictional claims in institutional affiliations. Responsibility for affiliations ultimately rests with the author, although the publisher may request changes be made to countries listed in affiliations t…
Source ↗Publisher website ·- Conflicts of interest Conflicts of interest
Authors must declare all relevant interests that could be perceived as conflicting. Authors should explain why each interest may represent a conflict. If no conflicts exist, the authors should state this. Submitting authors are responsible for co-authors declaring their interests. Conflicts of interest (COIs, also known as 'competing interests') occur when issues outside research could be reasonab…
Source ↗Publisher website ·- Data availability Data availability
Authors must include a data availability statement with their submission. When submitting a manuscript, submitting authors will be asked to select from several pre-written statements or use the text editor to tell us about data availability with regard to their submission. Review our Data Sharing Policy to understand which data availability statement is right for your submission.
Source ↗Publisher website ·- License & copyright Copyright and permissions
Authors retain the copyright of their manuscripts, and all open access articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not speci…
Source ↗Publisher website ·- Peer review Peer review
The journal follows a single-anonymized peer review model, for applicable article types. Information on the Peer Review model can be found here. Wiley's policy on the confidentiality of the review process is available here. All submitted articles are subject to assessment and peer review to ensure editorial appropriateness and technical correctness. Research published in the journal must be: Scien…
Source ↗Publisher website ·- Preprints Preprints
The journal accepts articles previously published on preprint servers, and does not consider this to compromise the novelty of the results. Articles based on content previously made public only on a preprint server, institutional repository, or in a thesis will be considered. The preprint should be cited.
Source ↗Publisher website ·- Trial registration / reporting guidelines Reporting guidelines
Authors are strongly encouraged to use appropriate reporting guidelines when preparing and submitting manuscripts, to maximize transparency and reproducibility. Our editors and reviewers are also encouraged to use them in the review process. Completed checklists should be provided in the supplementary files on submission. We particularly encourage the use of: CONSORT for randomized controlled tria…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Before you submit
Five checks before submitting to Sarcoma
- 1ScopeRecent output centres on Sarcoma Diagnosis and Treatment, Bone Tumor Diagnosis and Treatments.Check scope
- 2Article type and formatAbstract: ≤ 300 words; Reference style: Chicago; First submission: Free format: the journal's layout is not required.Author guidelines ↗
- 3English languagePolish grammar and academic style before you submit: it lowers the risk of rejection for language and improves your chances of acceptance.
- 4FeesUSD 820 (OpenAlex)Fee details
- 5Expected review time183 days · Median, submission to acceptance · 103 articles, last 24 months · CrossrefReview data
The checks are built from this page's data.
Profile
Publication details and official links
- Publisher
- Hindawi
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1357-714X
- Electronic ISSN
- 1369-1643
- Official links
- Journal homepage ↗OpenAlex
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Sarcoma
How long does peer review take at Sarcoma?
Based on the dates recorded on 103 articles published between November 2024 and November 2026 (the last 24 months), the median time from submission to acceptance is 183 days (interquartile range 131–257 days); authors report an average review time of about 14 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Sarcoma?
According to the journal's author guidelines: Abstract: ≤ 300 words; Reference style: Chicago; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Sarcoma based?
Of the 20 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (8), India (2) and Italy (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Sarcoma?
According to LetPub and DOAJ records, Sarcoma is indexed in Scopus. The journal's website also lists PubMed, Embase, CAS, CINAHL and DOAJ; that list has not been checked against each database.
Is Sarcoma open access, and what is the APC?
Sarcoma is a fully open-access journal. APC about USD 820.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .